1st Quarter - Report

AMERICAN DEFENSE INTERNATIONAL for ALGIPHARMA AS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 16, 2010 — Replaced
1st Quarter - Report (this page) Jul 15, 2010 $10,000 Replaced
1st Quarter - Amendment Oct 20, 2011 — Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Department of Defense Appropriations Bill, provisions relating to microbial biofilm research. National Defense Authorization Act, provisions relating to microbial biofilm research.

LobbyistCovered position, as disclosed
KATHERINE ELTZROTH New —
VAN HIPP Dep Asst Sec of Army, Prin Gen Counsel of Navy

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.